Menu Search
Equities

Hims & Hers Health Inc

HIMS*:MEX

Hims & Hers Health Inc

Actions
  • Price (MXN)314.84
  • Today's Change4.95 / 1.60%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Sep 19 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical records system, digital prescriptions and cloud-enabled pharmacy fulfillment. Its digital platform enables access to treatments for a range of conditions, including sexual health, men’s and women’s dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services. It offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. It offers pharmacy operation capabilities through its MedisourceRx, a 503B outsourcing facility in California.

  • Revenue in USD (TTM)1.07bn
  • Net income in USD18.10m
  • Incorporated2021
  • Employees1.05k
  • Location
    Hims & Hers Health Inc2269 Chestnut St, #523SAN FRANCISCO 94123United StatesUSA
  • Phone+1 (415) 851-0195
  • Fax+1 (302) 655-5049
  • Websitehttps://www.forhims.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.